GlaxoSmithKline PLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
GlaxoSmithKline PLC
CIK #0001131399
EDGAR Form CIK 2011 - 2024
3 [0001131399]
4 [0001131399]
5 [0001131399]
6-K [0001131399]
SC 13D [0001131399]
SC 13G [0001131399]
Form 3/4/5 Subject 2011 - 2024
Wave Life Sciences Ltd.
GSK plc
Spero Therapeutics, Inc.
23andMe Holding Co.
Theravance Biopharma, Inc.
CVRx, Inc.
Lyell Immunopharma, Inc.
Innoviva, Inc.
Decibel Therapeutics, Inc.
Bicycle Therapeutics PLC
Genocea Biosciences Inc
Pandion Therapeutics, Inc.
Nkarta, Inc.
Turning Point Therapeutics, Inc.
Progyny, Inc.
Orchard Therapeutics plc
Principia Biopharma Inc.
Fulcrum Therapeutics, Inc.
Morphic Holding, Inc.
ChemoCentryx, Inc.
Liquidia Technologies Inc
Constellation Pharmaceuticals Inc
Translate Bio, Inc.
Aileron Therapeutics, Inc.
HTG Molecular Diagnostics Inc
CRISPR Therapeutics AG
Applied Genetic Technologies Corp
Amicus Therapeutics Inc
Nupathe Inc
Concert Pharmaceuticals Inc
OncoMed Pharmaceuticals Inc
Response Genetics Inc
Human Genome Sciences Inc
Terms | Privacy | Guide
tony@aum13f.com